Differences between women and men in serial HIV prevalence and incidence trends

European Journal of Epidemiology - Tập 23 Số 6 - Trang 435-440 - 2008
Isabel Hurtado1,2, Ignacio Alastrué3, Julia del Amo4, Camila Alves dos Santos3, Inmaculada Ferreros1,2, Teresa Tasa3, Santiago Pérez-Hoyos1,5,2
1CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain
2Unitat d’Epidemiologia i Estadística, Escola Valenciana d’Estudis en Salut (EVES), Valencia, Spain
3Centro de Información y Prevención del SIDA de Valencia, Valencia, Spain
4Dpto. Salud Pública, Universidad Miguel Hernández de Alicante, Alicante, Spain
5Dpto. Enfermería Comunitaria, Medicina Preventiva y Salud Pública e Historia de la Ciencia, Universidad de Alicante, Alicante, Spain

Tóm tắt

Từ khóa


Tài liệu tham khảo

Rice BD, Payne LJ, Sinka K, Patel B, Evans BG, Delpech V. The changing epidemiology of prevalent diagnosed HIV infections in England, Wales, and Northern Ireland, 1997 to 2003. Sex Transm Infect. 2005;81:223–9. doi: 10.1136/sti.2004.012070 .

UNAIDS. Report on the global AIDS epidemic. Geneva. (2006).

EuroHIV. HIV/AIDS surveillance in Europe. Saintt-Maurice: Institut de la Veille Sanitarie; 2005.

Quinn TC, Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science. 2005;308:1582–3. doi: 10.1126/science.1112489 .

ONUSIDA. Situación sobre la epidemia de SIDA. www.onusida.org (2005).

De La Fuente L, Bravo MJ, Toro C, et al. Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes. J Epidemiol Community Health. 2006;60:537–42. doi: 10.1136/jech.2005.037333 .

De La Fuente L, Bravo MJ, Barrio G, et al. Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors. Clin Infect Dis. 2003;37(Suppl 5):S410–5. doi: 10.1086/377562 .

Barrasa A, del Romero J, Pueyo I, et al. Prevalence of the HIV infection in patients seen at specialized diagnosis centers in 9 cities in Spain from 1992 to 2001. Aten Primaria. 2004;33:483–8. doi: 10.1157/13061610 .

Jesús Castilla J, Lorenzo JM, Izquierdo A, et al. Características y tendencias de los nuevos diagnósticos de infección por el VIH, 2000–2004. Gac Sanit. 2006;20(6):442–8. doi: 10.1157/13096525 .

Hurtado I, Alastrue I, Ferreros I, et al. Trends in HIV testing, serial HIV prevalence and HIV incidence among persons attending a Center for AIDS Prevention from 1988 to 2003. Sex Transm Infect. 2007;83:23–8. doi: 10.1136/sti.2005.019299 .

Kim H-J, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335–51. doi: 10.1002/(SICI)1097-0258(20000215)19:3≤335::AID-SIM336≥3.0.CO;2-Z .

National Cancer Institute. Statistical research and applications branch [on-line]. http://srab.cancer.gov/software/joinpoint.html . 19-3-2005.

Stata Corp. Stata Statistical Sofware:Release 8.0. 2003.

Spittal PM, Craib KJ, Wood E, et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ. 2002;166:894–9.

Lum PJ, Sears C, Guydish J. Injection risk behavior among women syringe exchangers in San Francisco. Subst Use Misuse. 2005;40:1681–96. doi: 10.1080/10826080500222834 .

Riehman KS, Kral AH, Anderson R, Flynn N, Bluthenthal RN. Sexual relationships, secondary syringe exchange, and gender differences in HIV risk among drug injectors. J Urban Health. 2004;81:249–59. doi: 10.1093/jurban/jth111 .

Mehta SH, Galai N, Astemborski J, et al. HIV incidence among injection drug users in Baltimore, Maryland (1988–2004). J Acquir Immune Defic Syndr. 2006;43:368–72. doi: 10.1097/01.qai.0000243050.27580.1a .

Fuente de Hoz L, Brugal Puig MT, Ballesta Gómez R, et al. Metodología del estudio de cohortes del proyecto ITINERE sobre consumidores de heroína en tres ciudades españolas y características básicas de los participantes. Rev Esp Salud Publica. 2005;79:475–91. doi: 10.1590/S1135-57272005000400005 .

Jarlais D. The first and second decades of AIDS among injecting drug users. Br J Addict. 1992;87:347–53. doi: 10.1111/j.1360-0443.1992.tb01935.x .

Whynot EM. Women who use injection drugs: the social context of risk. CMAJ. 1998;159:355–8.

Barrasa A, Castilla J, del Romero J, et al. Sentinel surveillance of HIV infection in HIV test clinics, Spain 1992–2002. Euro Surveill. 2004;9:27–9.

Turmen T. Gender and HIV/AIDS. Int J Gynaecol Obstet. 2003;82:411–8. doi: 10.1016/S0020-7292(03)00202-9 .

Gatali M, Archibald C. Women and HIV. BMC Womens Health. 2004;4(Suppl 1):S27. doi: 10.1186/1472-6874-4-S1-S27 .